Effects of Cabozantinib, a Small Molecule Tyrosine Kinase Inhibitor, on the Immune Permissiveness of the Tumor Microenvironment and Immune-Mediated Killing of Tumor Cells

Meeting abstracts Combination therapy for the treatment of cancer is becoming increasingly important as the complexity of carcinogenesis and the availability of targeted therapies continues to expand. Successful combination therapy would target the primary tumor and distant metastases from multiple